Official recall notice

FDA DrugClass IINotable

FDA Recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 1000-count bottles, Rx Only, Manufactured for

Recall date
2026-09-02
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Subpotent Drug

Product description

Subpotent Drug

Affected products

Lot #: D2401983, Exp. Date 08/31/2026; D2402640, D2402641, Exp. Date 11/30/2026; D2500224, Exp. Date 01/31/2027.

Verify with the official notice →
Share:

Related Recalls

2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-45
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457
ACCORD HEALTHCARE, INC.
2026-09-02 · FDA_DRUG
FDA Recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Only, Manufactured for:
ACCORD HEALTHCARE, INC.